Ongoing CE Activities

36th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series

A Multidisciplinary Approach to Individualized Patient Care-Breast Cancer

Applying Personalized Medicine to Oncology Care

Breast Cancer: Genetic Testing and Management

Breast Cancer Prevention, Screening, Diagnosis, and Treatment

Breast Cancer Update, Issue 3, 2019: ER-Positive Edition

Breast Cancer Update: Triple-Negative Edition

Cancer Summaries and Commentaries™: Update from Barcelona: Advances in the Treatment of Breast Cancer

Challenges With the 8th Edition of the AJCC Staging Manual - Staging of Breast Cancer

Community Practice Connections™: 1st Annual Precision Medicine Symposium: An Illustrated Tumor Board

Community Practice Connections™: 3rd Annual International Congress on Oncology & Pathology™

Community Practice Connections™: Curbing the Opioid Epidemic: Taking Steps to Improve Postsurgical Outcomes for Your Patients With Breast Cancer

Community Practice Connections™: The Latest Advances on PI3K Inhibition in Breast Cancer: What You Need to Know

Current and Future Directions in PARP Inhibition

Data + Perspectives: Clinical Investigators Explore the Current and Future Management of Triple-Negative Breast Cancer

Emerging Considerations in Triple-Negative Breast Cancer: Focus on Immunotherapy

Empowering Oncology Teams to Improve Care Quality for Women with Advanced or Metastatic HR+/HER2- Breast Cancer

ER-Negative/PR-Positive Breast Cancer: Real or Artifact?

Evidence-based Integrative Therapies in Breast Cancer

Expert Insights on Triple-Negative Breast Cancer: Preparing for the Next Wave of Treatments

Genetic/Familial High-Risk Evaluation in Patients With Breast Cancer

HR+/HER2-Negative Breast Cancer: Revolutions in Precision Medicine with PI3K Inhibitors

Implementation and Implications of AJCC Cancer Staging Manual, 8th Edition for Breast Cancer Staging

Improving Outcomes in HER2+ Early Breast Cancer

Improving Outcomes in HER2+ Breast Cancer: Analysis and Application of Evolving Data and Best Practices

Interactive Tumor Panel: Clinical Investigators Discuss Emerging Research and Actual Cases of Patients with Breast Cancer

JADPRO: Advances in Oral Oncolytic Agents for Breast Cancer and Recommendations for Promoting Adherence

Locoregional Treatment of Breast Cancer Including SABCS Updates

Management of Lymphedema After Breast Cancer Treatment

Community Practice Connections™: Meeting Key Unmet Clinical Needs in HER2-Positive Breast Cancer: Aligning the Data with Strategy to Improve Patient Outcomes

NCCN GUIDELINES® UPDATES: Breast Cancer- Multigene Testing in Breast Cancer

Navigating the Rapidly Evolving Treatment Landscape for HER2+ Metastatic Breast Cancer

NCCN 2020 Congress Series: Breast Cancer With Updates From 2019 San Antonio Breast Cancer Symposium

NCCN Guidelines Update: Treatment of Hormone-Sensitive Advanced Breast Cancer

NCCN Harmonized Guidelines for Sub-Saharan Africa

Neoadjuvant & Adjuvant Therapies for Early Stage Breast Cancer

New and Emerging Treatment Options for Refractory HER2+ Metastatic Breast Cancer

New Systemic Therapies for Metastatic Breast Cancer Including SABCS Updates

Oncology Today with Dr Neil Love: Immune Checkpoint Inhibition in Breast Cancer

PARP Inhibition Holds Promise for a Broader Range of Triple-Negative Breast Cancers

PARP Inhibitors in Breast Cancer: Expert Perspectives on Clinical Application & Genetic Testing

Proceedings from the First Annual Oncology Nursing Retreat ER-Positive Metastatic Breast Cancer

Proceedings from the First Annual Oncology Nursing Retreat HER2-Positive and Triple-Negative BC

Rapid Reviews in Oncology® from Chicago: Practice-Changing Data in Breast Cancer

Real-World Strategies to Transform a Triple-Negative Breast Cancer Diagnosis Into Positive Patient Outcomes

Recognition and Intervention for Women With Fluid That Develops Around Breast Implants

NCCN Updates in the treatment of HER-2 Positive Breast Cancer

Enduring CME Activity: School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio

Should a Patient with a 2 cm HER2+/TNBC Clinically Node Negative Receive Neoadjuvant Therapy?

The Evolving Role of PARP Inhibitors for Cancer Treatment

The Jackson Laboratory Genetic Testing for Breast Cancer

The New Backbone of Treatment for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer - Animated Whiteboard View

The Role of Lifestyle and the Environment in Breast Cancer Risk

Utility of MultiGene Assays in Management of Early Stage Breast Cancer

When Should Women With a Family History of Breast Cancer Start Screening?